---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-031205"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2026-06-30T12:30:20+00:00"
generated_at: "2026-06-30T12:35:14.202233+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical signs manufacturing agreement with Sanmina for LIBERTY System

## Summary
- Entered into Letter of Agreement with Sanmina Corporation to manufacture the LIBERTY Endovascular Robotic System.
- Agreement expands manufacturing capacity to meet rising demand from existing and new accounts in U.S. and internationally.
- Expected to improve operating efficiencies, lower costs, and expand gross margins as part of cost reduction strategy.
- Sanmina, a global manufacturing leader, provides second manufacturing site and potential for regional scaling.
- Microbot plans to increase U.S. sales footprint to Western U.S. later this year; recent clearance in Israel, CE Mark progress.

## SEC filing metadata
- accession: 0001493152-26-031205
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2026-06-30T12:30:20+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315226031205/0001493152-26-031205-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315226031205/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-031205
- JSON: https://secwatch.observer/filing/0001493152-26-031205.json
- Plain text: https://secwatch.observer/filing/0001493152-26-031205.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.